NOX4 and pulmonary fibrosis: Additionally, these inhibitors inhibit the TGF-β-induced increase in NOX4 and ACTA2 and the reduction in SOD2 while increasing Nrf2 activity, thereby reducing the level of ROS in cells and fibroblast activation and promoting the regression of pulmonary fibrosis in mice [185, 186].